Stroke risk in atrial fibrillation: do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?

Stroke risk in atrial fibrillation: do we anticoagulate CHADS₂ or CHA₂DS₂-VASc ≥1, or higher?

Research output: Contribution to journal › Journal article › Research › peer-review

@article{420efa81265649d0a597470a6572d090,

title = "Stroke risk in atrial fibrillation: do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?",

author = "Olesen, \{Jonas Bjerring\} and Christian Torp-Pedersen",

year = "2015",

doi = "10.1160/TH15-02-0154",

language = "English",

volume = "113",

pages = "1165--1169",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Georg Thieme Verlag",

number = "6",

}

TY - JOUR

T1 - Stroke risk in atrial fibrillation

T2 - do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?

AU - Olesen, Jonas Bjerring

AU - Torp-Pedersen, Christian

PY - 2015

Y1 - 2015

U2 - 10.1160/TH15-02-0154

DO - 10.1160/TH15-02-0154

M3 - Journal article

C2 - 25743201

SN - 0340-6245

VL - 113

SP - 1165

EP - 1169

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 6

ER -